General Surgery Devices Market Worth $26.5 Billion By 2026

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Lymphoma Treatment Market Size Worth $26.4 Billion By 2026

The global lymphoma treatment market size is expected to reach USD 26.4 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.5%. Rising research activities for development of new treatments and increasing product line extension are likely to expedite growth. Increasing commercialization of novel drugs are further expected to drive the growth.

Availability of wide variety of products is further expected to aid growth. For instance, in January 2019, BeiGene received a breakthrough therapy designation by the U.S. FDA for its product Zanubrutinib for treating mantle cell lymphoma in adults. This drug is currently in late-stage clinical trial and is expected to be launched during the forecast period.

Growing awareness about early diagnosis of lymphoma among healthcare professionals & patients and rising government funding for R&D are some factors expected to propel market growth. For instance, institutes such as National Cancer Institute receives funding from the U.S. Congress to support cancer-related research and associated activities.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/lymphoma-market

Further key findings from the report suggest:

Non-Hodgkin lymphoma held the largest share in 2018 owing to prevalence of non-Hodgkin lymphoma and presence of blockbuster drugs.
Hodgkin lymphoma is expected to be the fastest growing segment due to presence of strong product pipeline and increase in the number of label extension for existing drugs.
Based on drug, Revlimid held the highest share in 2018 and is expected to grow at a significant rate during the forecast period. This can be attributed to growing use of this product in cancer treatment regimens.
Rituxan/MabThera held the second largest share in 2018 owing to increasing use of this product in multiple indications and high prescription rate in major markets such as the U.S., Europe, and Japan.
North America dominated in 2018, followed by Europe. This can be attributed to well-established healthcare infrastructure, high R&D expenditure, availability of novel drugs, and presence of key players.
Asia Pacific is expected to be the fastest growing over the forecast period owing to increase in commercialization of products, rise in awareness about diseases and high unmet clinical needs.
Some of the major players are Celgene Corporation; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Seattle Genetics, Inc.; Merck & Co., Inc.; Johnson & Johnson; Takeda Pharmaceutical Company Ltd.; Abbott Laboratories; and Eli Lilly and Company.
Key players for lymphoma treatment market are adopting strategies such as collaborations, mergers & acquisitions, product development, product line extension, and regional expansion to increase their share. For instance, Seattle Genetics collaborated with Takeda Pharmaceuticals for commercialization of Adcetris in different regions other than North America.

Preimplantation Genetic Testing Market Worth $107.3 Million By 2024

The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.

High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/preimplantation-genetic-testing-pgt-market

Further key findings from the report suggest:

Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018
Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future
Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018
Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment
Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy
Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures
Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries
Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina’s PGT products in EMEA and America.

Europe MRO Distribution Market Size Worth $222.11 Billion By 2028

The Europe MRO distribution market size is expected to reach USD 222.11 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 1.6% from 2021 to 2028. The rise in scheduled maintenance and increasing investments in repair operations are expected to ascend the market growth over the forecast period.

Prominent European industries have adopted integrated repair, maintenance, and operation service concepts for improvements in the equipment and services in critical operations. Many industrial units adopted this change post-recession period and are likely to continue in the projected time. Therefore, the demand for Maintenance, Repair, & Overhaul (MRO) distribution is expected to remain high.

The untapped markets are benefitted owing to the emergence of e-commerce platforms in the European region, thus the penetration of MRO products in the region has escalated. Moreover, the established players in the region have adopted the strategy of acquiring small-scale players to enhance the market presence.

Major players in the regional market are employing several strategies focusing on digital marketing, pricing, product placement, and communication to improve supply channels and enhance sales operations. These enhanced sales processes and standardized sales tools are anticipated to upscale the MRO industry growth in the upcoming future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-maintenance-repair-overhaul-mro-distribution-market

Further key findings from the study suggest:

The machine consumables product segment accounted for the largest share of 30.2% in 2020 on account of the increasing focus of the end-users on the maintenance and upkeep of critical equipment in order to maintain and enhance their performance and operational lifetime
The external MRO service type segment is anticipated to witness the fastest growth from 2021 to 2028 owing to the increasing contracts to third-party MRO service providers by the product manufacturers to increase the geographical operation
The preventive/scheduled maintenance type segment accounted for the largest share of 58.8% in 2020 and is projected to witness significant growth over the forecast period owing to its rising adoption in order to reduce the breakdown and maintenance time
The machinery and equipment application segment is projected to expand at the fastest CAGR from 2021 to 2028 on account of the growing demand from a diverse range of industry verticals, including construction, automotive, and metalworking
Germany accounted for the largest share of 21.8% in 2020 owing to the high adoption of preventive and scheduled MRO among the manufacturers operating in the country

Smart Parking Systems Market Size Worth $14.3 Billion By 2027

The global smart parking systems market size is expected to reach USD 14.3 billion by 2027, registering a CAGR of 17.4% over the forecast period, according to a new report by Grand View Research, Inc. An anticipated upsurge in demand for these systems for transport transit and commercial applications is expected to drive the growth in the market. Rising demand for hassle-free parking coupled with the advances in technology are anticipated to propel market growth over the forecast period.

Favorable government initiatives and increasing public sector funding to roll out solutions aimed at addressing traffic congestion issues are anticipated to drive the market. Furthermore, the inclusion of sophisticated features, such as voice guidance and auto-payment options enabled through smartphone apps, are also projected to fuel the growth of the market. Various parking lots are integrating Automatic Number Plate Recognition (ANPR) systems to effectively manage vehicle at parking areas and access control systems.

Ensuring adequate parking space is turning out to be a challenge for civic administrations as the number of automobiles continues to increase. The demand for intelligent systems is rising across the globe as a result. These systems can effectively address traffic congestion issues and space-related concerns. They can also open potential opportunities for reusing commercial and municipal areas and garages, thereby reducing fuel consumption, curtailing vehicular emissions, and subsequently making the cities cleaner and greener.

However, a looming lack of funding initiatives as well as organizational awareness about the advantages associated with smart parking, particularly in underdeveloped regions, is anticipated to restrain the growth of the market over the forecast period. Moreover, the non-availability of supporting infrastructure in these regions is further hampering market growth. The high implementation cost of these systems is anticipated to act as a challenge for smart parking systems industry growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/smart-parking-system-market

Further key findings from the report suggest:

The hardware segment is expected to continue its dominance over the forecast period due to the decisive role various hardware components play in detecting the presence of the vehicles in parking slots
The signage segment is expected to grow significantly over the forecast period, as signage can help in preventing confusions and the resultant mishaps by guiding drivers in appropriate directions.
The parking guidance system uses communication, traffic monitoring, and processing and variable message sign technologies to guide vehicle drivers to available spaces
The consulting services segment is expected to witness significant growth over the forecast period. Consulting services envisage providing an analysis of the volume of traffic that needs to be managed and recommending potential solutions according to the need
Off-street segment dominated the market as it offers easy and swift pay-and-park solutions, which can distribute tickets automatically, thereby reducing congestions at entrances.
The government segment is expected to witness phenomenal growth owing to the increasing need for managing on-road vehicles and minimizing fuel emissions
The European region is anticipated to continue its dominance over the forecast period. The continued interest of automobile manufacturers in the region in developing intelligent parking systems is anticipated to drive the growth of the regional market.
On-demand valet parking coupled with the increasing demand for parking management systems at public venues,including shopping malls and sports complexes, in countries, such as Japan and China, is expected to fuel the demand for these systems in the Asia Pacific region.
The key players in the market include Amano McGann, Inc.; SKIDATA AG.; Parkmobile LLC; ParkMe, Inc.; Robert Bosch GmbH; and Nedap N.V.

Commercial Vehicles Market Size Worth $2.27 Trillion By 2025

The global commercial vehicles market size is expected to reach USD 2.27 trillion by 2025, according to a study conducted by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.1% during the forecast period. Increased urbanization, coupled with rising spending on infrastructure development in emerging economies such as China, India, and Turkey, are expected to drive the market over the forecast period. Several suppliers are shifting their focus on improving R&D capabilities while enhancing operational efficiency, which is also projected to play a pivotal role in boosting market growth.

In addition, increasing penetration of electric commercial vehicles is also anticipated to contribute toward market expansion over the coming years. Adoption of electric vehicles (EVs) is primarily driven by need to meet emission reduction standards and regulations enforced by government bodies worldwide. Commercial vehicle telematics is another trend that is gaining traction and is anticipated to have a positive impact on the market over the forecast period.

To meet changing market needs, original equipment manufacturers (OEMs) across the globe are focusing on integrating innovative technologies, such as keyless entry/ignition, engine diagnostics, mobile connectivity, and an array of novel applications that assist in vehicle control. All these efforts by OEMs are expected to significantly contribute to global market growth over the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/commercial-vehicle-market

Further key findings from the study suggest:

Expanding e-commerce industry and availability of easy finance options are anticipated to play a key role in boosting the commercial vehicles market growth
Increasing spending on infrastructural development and efforts taken by OEMs to provide value-added services focused on enhancing in-vehicle experience are projected to drive market demand
The global market is expected to register a volume-based CAGR of over 6.0% from 2018 to 2025, primarily as a result of sustained economic activity in emerging markets
The light commercial vehicles (LCVs) segment recorded consistent growth from 2014 to 2017 and this trend is expected to continue over the forecast period due to expansion into newer markets such as Africa and Southeast Asia
The logistics segment is anticipated to witness high demand for commercial vehicles, primarily due to rise in trade and e-commerce activities across the globe
Rapid urbanization and improving road infrastructure in Asia Pacific are projected to drive the region to register a revenue-based CAGR of more than 8.0% from 2018 to 2025
The market is marked by the presence of numerous participants such as Tata Motors, Volkswagen AG, Ashok Leyland, Volvo Car Corporation, and General Motors. These players implement various inorganic and organic growth strategies to maintain their presence and withstand intense competition.

X-ray Systems Market Size Worth $10.43 Billion By 2025

The global x-ray systems market size is expected to reach USD 10.43 billion by 2025, according to a new report by Grand View Research, Inc., registering a 2.9% CAGR during the forecast period. Rising investments in medical technology, increasing R&D activities, and a surge in product launches are key factors driving market growth.

Prominent modalities include radiography, fluoroscopy, and computed radiography. Computed radiography systems are the most preferred systems, as they provide sharp images in a shorter time. Moreover, the imaging plates can be reused. Fluoroscopy is also gaining prominence in developed countries such as the U.S. and Canada.

X-ray systems can be stationary or portable. Even the stationary systems dominated the market in 2017 in terms of revenue, the portable kind are poised to witness faster growth. Stationary radiography systems have significant demand in developing countries where adaption to new technology is slow. Portable systems are preferred over stationary variants due to their mobility, which makes them more convenient and flexible for use.

Some of the key players in this market are Koninklijke Philips N.V.; GE Healthcare; Hitachi, Ltd.; Shimadzu Corporation, Fujifilm Medical Systems; Siemens Healthineers; Canon Medical Systems Corporation; Carestream Health; Hologic, Inc.; and Biosign. Expansion of regional and service portfolios and mergers and acquisitions are some of the leading strategic undertakings adopted by these players. For instance, in December 2016, Hitachi acquired Kurt & Kurt, a medical diagnostic system provider, to expand its businesses in Turkey.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/x-ray-systems-market

Further key findings from the report suggest:

The global X-ray systems market was valued at USD 8.3 billion in 2017 and is expected to at a modest pace over the forecast period
Based on type, digital systems are anticipated to grow at the fastest rate as analog systems fade out
By modality, the computed radiography segment was valued at USD 2.9 billion in 2017, emerging as the market leader. Fluoroscopy will register the fastest growth over the forecast period
While hospitals enjoy the dominant share on the basis of end use, the diagnostic centers segment is anticipated to register a CAGR of 3.6% from 2018 to 2025

Continuous Peripheral Nerve Block Catheters Market Worth $292.8 Million By 2025

The global continuous peripheral nerve block (cPNB) catheters market is expected to reach USD 292.8 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.2% during the forecast period. Growing orthopedic surgery volumes resulting from the rising prevalence of osteoarthritis and increasing preference for ambulatory surgical centers are the key growth stimulants for the cPNB catheters market. According to the Healthcare Cost and Utilization Project (HCUP), over 546,000 total hip arthroplasty and 789,500 total knee arthroplasty procedures were performed in the U.S. in 2014. Of these, almost 70.0% of hip replacement operations are performed to relieve symptoms of osteoarthritis. This shows the potential demand for these devices in the coming years.

The rate of ambulatory surgeries is escalating due to a growing number of ambulatory surgical centers (ASCs), shortened recovery time, and continued improvements in regional anesthesia techniques. Costs of surgeries in ASC settings are approximately 60.0% less in comparison to those performed in hospitals. The recent inclusion of ambulatory surgeries for reimbursement of knee replacement surgeries by the Centers for Medicare & Medicaid Services in the U.S., along with the inherent benefits of cPNB usage, is likely to boost the demand for these catheters in the coming years.

On the competitive front, the leading players in this space are Pajunk GmbH and B. Braun Melsungen AG. Companies with wider distributor reach, larger product portfolio, and advanced technologies are seen to lead the space. Some other key players are Teleflex, Halyard, and Vygon, which are projected to have a stronger market presence by 2025. Less prominent players trailing behind include Ace Medical, Temena, Epimed International, and others.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/continuous-peripheral-nerve-block-cpnb-catheters-market

Further key findings from the study suggest:

The ultrasound segment, based on the insertion technique, held the dominant share of 48.2% owing to associated advantages including improved block quality, faster and longer block duration, and a reduced dose of local anesthetic
Lower extremity surgeries represented the most prominent position in the market due to the increasing number of hip and knee replacement surgeries involving the use of cPNB catheters
The ambulatory surgical centers segment is estimated to exhibit a noteworthy CAGR during the forecast period. This can be attributed to related benefits such as shorter waiting list, quick discharge, reduced overall procedural cost, and treatment of a higher number of patients
Hospitals held 58.5% of the cPNB catheters market
Europe is anticipated to register a CAGR of 6.4% during the forecast period owing to the high number of surgeries performed in this region, which involve cPNB usage to manage postoperative pain.

eClinical Solutions Market Worth $15.7 Billion By 2027

The global eClinical solutions market size is expected to reach USD 15.7 billion by 2027, according to a new report by Grand View Research, Inc., progressing at a CAGR of 13.8% during the forecast period. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the market over the forecast period.

Moreover, digital transformation in the field of clinical trials and preference for data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.

Adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision making in every stage of the development process. They also help reduce cost and time between development phases by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which is helpful in making quick decisions.

Market players engage in new product development and strategic alliances, including partnership agreements, promotional activities, and acquisitions, to keep market rivalry high. For instance, in October 2017, Oracle entered into a collaboration with Healthx Inc. to provide SaaS solutions to healthcare payers for core administration and digital engagement.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

CTMS led the eClinical solutions market by product in 2019 owing to benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
By delivery mode, cloud-based systems are anticipated to exhibit the highest CAGR during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
CROs held the largest share in the market in 2019 on the basis of end use. The segment is projected to expand at a remarkable pace during the forecast period owing to growing inclination of pharmaceutical companies to reduce overall expenditure
Key players operating in the market include DATATRAK International, Inc.; IBM Watson Health; Medidata Solutions Inc.; Oracle Corporation; BioClinica; PAREXEL International Corporation; CRF Health; OmniComm Systems Inc.; and ERT. Most companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share.

Healthcare Cloud Computing Market Size Worth $27.8 Billion By 2026

The global healthcare cloud computing market size is expected to reach USD 27.8 billion by 2026, according to a new report by Grand View Research, exhibiting a CAGR of 11.8% over the forecast period. The associated benefits of data analytics and increase in demand for flexible & scalable data storage by healthcare professionals is expected to drive the demand for these services over the forecast period.

Healthcare organizations are digitalizing their IT infrastructure and deploying cloud servers to improve features of systems. These solutions help organizations in reducing infrastructure cost & interoperability issues and aid in complying with regulatory standards. Hence, rising demand from health professionals to curb IT infrastructure costs and limit space usage are anticipated to boost market growth over the forecast period.

Increase in government initiatives undertaken to develop and deploy IT systems in this industry is one of the key drivers of this market. Moreover, increase in partnerships between private & public players and presence of a large number of players offering customized solutions are some of the factors anticipated to drive demand in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market

Further key findings from the report suggest:

Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted for the largest revenue share in application segment in 2018
Financial management segment held 23.0% share of the non-clinical segment in 2018 while billing and accounts management is expected to grow at the considerable CAGR during the forecast period
Private deployment model dominated the overall market owing to its benefits and ease of usage
Software as a Service (SaaS) model accounted for the largest revenue share as of 2018 as it is widely accepted. This model enables access to applications on a cloud from various devices
Pay-as-you-go pricing model is anticipated to gain popularity in the coming years, as the consumer only pays for services being used
North America dominated the market with a share of over 55.0% in 2018. This can be attributed to an increase in demand from payers as well as providers
Some key players of this healthcare cloud computing market include Athenahealth, Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic Systems Corporation, Dell Inc., and Sectra AB
Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years.